Abstract
Taban-Arshan extract decreased expression of T-lymphocyte activation markers, normalized T-cell-mediated immunity, and suppressed increased activity of natural killer receptors during culturing with lymphocytes of patients with atopic bronchial asthma. Taban-Arshan extract normalized activation processes in the B-cell immunity and stimulated expression of receptors of activation-induced apoptosis.
Similar content being viewed by others
REFERENCES
V. N. Lakusta, Lin Chzhi Shen, and N. V. Shinkarenko, Chzhen-Tszu Therapy of Asthma [in Russian], Kishinev (1995).
G. V. Poryadin, A. N. Kazimirskii, Zh. M. Salmasi, et al., Klin, Patofiziol., No. 1, 5–11 (2002).
A. G. Chuchalin, Immunocorrection in Immunology [in Rus-sian], Moscow (1989).
A. A. Yarilin, Fundamentals of Immunology [in Russian], Moscow (1999).
A. Kumanogoh, C. Watanabe, I. Lee, et al., Immunity, 13, 621–631 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Semenova, L.Y., Salmasi, Z.M., Kazimirskii, A.N. et al. Taban-Arshan: Immunocorrector in Atopic Bronchial Asthma. Bulletin of Experimental Biology and Medicine 138, 65–66 (2004). https://doi.org/10.1023/B:BEBM.0000046941.60149.1e
Issue Date:
DOI: https://doi.org/10.1023/B:BEBM.0000046941.60149.1e